Skip to content

Hemab Therapeutics Holdings, Inc.

COAG

CIK 0002114044

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
—
Q1 May 2026
EPS Diluted (TTM)
—
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$49.86M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
46.71M sh
Q1 May 2026

Recent filings